使用现实世界数据集和药物相互作用网络分析ruxolitinib的不良事件
Hideyuki Tanaka1,2, Mika Maezawa1, Mizuki Tanaka1
1Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu-shi, Japan.
SAGE open medicine
|June 26, 2025
概括
卢克索利提尼布与贫血和细菌感染等不良事件有关,正如日本不良药物事件报告分析所显示的那样. 需要进一步的研究,以了解这些ruxolitinib副作用背后的药理机制.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 血液学 血液学 血液学
背景情况:
- 鲁克索利提尼布是一种Janus激酶 (JAK) 抑制剂,用于骨髓纤维化,真多细胞血和移植对宿主疾病.
- 了解与药物相关的不良事件对于患者的安全和有效治疗至关重要.
研究的目的:
- 通过使用日本药物不良事件报告,调查ruxolitinib和不良事件之间的关联.
- 为了确定潜在的药物基因相互作用和生物途径涉及ruxolitinib的不良影响.
主要方法:
- 来自日本不良药物事件报告数据库 (2014年1月 - 2024年3月) 的病例报告的回顾性分析.
- 根据倾向评分调整的报告几率比率 (ROR) 分析,以识别不良事件信号.
- 建立药物-基因相互作用网络和功能/通路丰富分析.
主要成果:
- 在贫血 (ROR 18.49),骨髓抑制 (ROR 4.70),败血症 (ROR 5.14) 和疹 (ROR 6.40) 中发现了显著的关联.
- 与ruxolitinib相互作用的基因在与贫血和细菌感染相关的生物过程中得到了丰富.
- 一些不良事件,如间歇性肺病 (ROR 0.33),显示出一种保护性关联.
结论:
- 鲁克索利提尼布可能与不良事件相关,包括贫血和细菌感染.
- 功能性丰富分析强调了特定生物途径在鲁克索利提尼布诱导的毒性中的作用.
- 需要进一步研究与ruxolitinib相关的血液毒性和感染的药理机制.
相关概念视频
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
240
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
240
Drug-Receptor Interactions
6.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.1K
Factors Affecting Protein-Drug Binding: Drug Interactions
291
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
291
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K


